Skip to main content
. Author manuscript; available in PMC: 2015 Jan 26.
Published in final edited form as: Clin Lung Cancer. 2010 Nov 1;11(6):405–411. doi: 10.3816/CLC.2010.n.052

Figure 3. Intratracheal Injection Administration of 5-Azacytidine Decreases by 5-fold the Reduction in the WBC Count as Compared With Intravenous Injection 5-Azacytidine.

Figure 3

5-Aza was administered I.T. (red dots) or I.V. (yellow dots) at a dose of 90 mg/kg. Control mice were not given any treatment (blue dots). Blood was drawn on days 0, 4, 7, 14, and 28 after treatment. White blood cells were counted after removal of red blood cells. The data of each group (5-8 mice each) are mean ± standard deviation.

Abbreviations: 5-Aza = 5-azacytidine; I.T. = intratracheal injection; I.V. = intravenous injection; WBC = white blood cells